CoChat

Tumor necrosis factor blocking therapy alters joint inflammation and hypoxia

Kennedy, Aisling, Ng, Chin Teck, Chang, Ting Cheng, Biniecka, Monika, O'Sullivan, Jacintha N., Heffernan, Eric, Fearon, Ursula, Veale, Douglas J. · 2011 · Arthritis & Rheumatism
Cited by 67

The DOI matches its Crossref record.

Abstract

Objective: To examine the effect of tumor necrosis factor (TNF) blocking therapy on hypoxia in vivo, macroscopic and microscopic inflammation, and magnetic resonance imaging (MRI) results in patients with inflammatory arthritis. Methods: Patients with inflammatory arthritis (n = 20) underwent full clinical assessment, arthroscopy, synovial biopsy, and MRI before and after initiation of biologic therapy. Macroscopic synovitis/vascularity was assessed with a visual analog scale, and tissue P O2 (tP O2) was measured at arthroscopy using a Licox probe. Cell‐specific markers (CD4, CD8, CD68, CD20, and CD19) and blood vessel maturity were quantified by immunohistologic analysis and dual‐immunofluorescence factor VIII/α‐smooth muscle actin staining, respectively. Contiguous gadoteric acid–enhanced MRI of the target knee was used to assess synovial enhancement. Results: Biologic therapy responders showed a significant increase of tP O2 in vivo (P < 0.05). This response was associated with significant reductions in 28‐joint Disease Activity Score using the C‐reactive protein level (DAS28‐CRP) (P = 0.012), macroscopic synovitis (P = 0.017), macroscopic vascularity (P = 0.05), CD4+ T cells (P < 0.041), and CD68+ macrophages (P < 0.011). Blood vessel numbers were also reduced in responders; however, this did not reach statistical significance. Strong inverse correlations were demonstrated between changes in tPo 2 levels and changes in DAS28‐CRP (r = −0.53, P < 0.001), CD4 (r = −0.44, P < 0.026), CD68 (r = −0.46, P < 0.003), and macroscopic vascularity (r = −0.314, P = 0.049) after therapy. Furthermore, changes in inflammation as measured by MRI showed a strong inverse correlation with tP O2 levels (r = −0.688, P < 0.002) and positive correlations with CRP levels (r = 0.707, P = 0.001), macroscopic synovitis (r = 0.457, P = 0.056), macroscopic vascularity (r = 0.528, P= 0.017), CD4 (r = 0.553, P < 0.032), and CD68 (r = 0.670, P < 0.002) after therapy. Conclusion: This is the first study to show that successful biologic therapy significantly improves in vivo synovial hypoxia. Changes are strongly associated with changes in macroscopic and microscopic measures of joint inflammation and MRI improvement. These data further strengthen the concept that hypoxia is an important event driving synovial inflammation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/art.30221

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

Metadata

Authors
Kennedy, A., Ng, C. T., Chang, T. C., Biniecka, M., O'Sullivan, J. N., Heffernan, E., Fearon, U., & Veale, D. J.
Venue
Arthritis & Rheumatism
Publisher
Wiley
Published
2011-03-30
Volume
63
Issue
4
Pages
923-932
ISSN
  • 0004-3591 (ISSN-L)
  • 1529-0131
OpenAlex
W1967494574
Cited by
67
References
0
FWCI
3.75
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.